{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:42:49Z","timestamp":1780090969854,"version":"3.54.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Natural Scientific Foundation of China","award":["81472502"],"award-info":[{"award-number":["81472502"]}]},{"name":"Liaoning Science and Technology Grant","award":["2013021077"],"award-info":[{"award-number":["2013021077"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13046-016-0307-1","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T20:56:56Z","timestamp":1455310616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression"],"prefix":"10.1186","volume":"35","author":[{"given":"Jing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Na","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ling","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,13]]},"reference":[{"key":"307_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893\u2013917.","journal-title":"Int J Cancer"},{"issue":"12","key":"307_CR2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/00016340802483000","volume":"87","author":"CG Hannibal","year":"2008","unstructured":"Hannibal CG, Cortes R, Engholm G, Kjaer SK. Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period 1978\u20132002. Acta Obstet Gynecol Scand. 2008;87(12):1353\u201360.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9859","key":"307_CR3","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095\u2013128.","journal-title":"Lancet"},{"key":"307_CR4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2012.12.016","volume":"129","author":"G Chornokur","year":"2013","unstructured":"Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129:258\u201364.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"307_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2010.09.008","volume":"300","author":"N Ahmad","year":"2011","unstructured":"Ahmad N, Kumar R. Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Lett. 2011;300(1):1\u20139.","journal-title":"Cancer Lett"},{"key":"307_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","volume":"69","author":"SM Eisenkop","year":"1998","unstructured":"Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol. 1998;69:103\u20138.","journal-title":"Gynecol Oncol"},{"key":"307_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-014-0113-6","volume":"33","author":"WP Zhang","year":"2014","unstructured":"Zhang WP, Zhang T, Jin RS, Zhao HC, Hu J, Feng B, et al. MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer. J Exp Clin Cancer Res. 2014;33:113.","journal-title":"J Exp Clin Cancer Res"},{"key":"307_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704\u201314.","journal-title":"Nat Rev Genet"},{"key":"307_CR9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncb1681","volume":"10","author":"Q Huang","year":"2008","unstructured":"Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, et al. The microRNAs miR-373 and miR-520c promote tumor invasion and metastasis. Nat Cell Biol. 2008;10:202\u201310.","journal-title":"Nat Cell Biol"},{"key":"307_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","volume":"449","author":"L Ma","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Weinberg RA. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682\u20138.","journal-title":"Nature"},{"key":"307_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13046-015-0253-3","volume":"34","author":"JQ Tao","year":"2015","unstructured":"Tao JQ, Zhi XF, Zhang XY, Fu M, Huang H, Fan Y, et al. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. J Exp Clin Cancer Res. 2015;34:139.","journal-title":"J Exp Clin Cancer Res"},{"key":"307_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-015-0125-x","volume":"34","author":"J Xiang","year":"2015","unstructured":"Xiang J, Bian CD, Wang H, Huang SS, Wu DL. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. J Exp Clin Cancer Res. 2015;34:8.","journal-title":"J Exp Clin Cancer Res"},{"key":"307_CR13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ncomms1555","volume":"2","author":"H Zhang","year":"2011","unstructured":"Zhang H, Hao Y, Yang J, Zhou Y, Li J, Yin S, et al. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun. 2011;2:554.","journal-title":"Nat Commun"},{"issue":"7","key":"307_CR14","doi-asserted-by":"crossref","first-page":"e67686","DOI":"10.1371\/journal.pone.0067686","volume":"8","author":"S Majid","year":"2013","unstructured":"Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K, et al. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One. 2013;8(7):e67686.","journal-title":"PLoS One"},{"key":"307_CR15","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1111\/j.1742-4658.2009.07014.x","volume":"276","author":"A Salvi","year":"2009","unstructured":"Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, et al. MicroRNA-23b mediates urokinase and c-met down modulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J. 2009;276:2966\u201382.","journal-title":"FEBS J"},{"key":"307_CR16","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1158\/0008-5472.CAN-12-2181","volume":"72","author":"S Majid","year":"2012","unstructured":"Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS, et al. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res. 2012;72:6435\u201346.","journal-title":"Cancer Res"},{"key":"307_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13046-015-0209-7","volume":"34","author":"J Guo","year":"2015","unstructured":"Guo J, Wang M, Liu XH. MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma. J Exp Clin Cancer Res. 2015;34:91.","journal-title":"J Exp Clin Cancer Res"},{"key":"307_CR18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-015-0192-z","volume":"34","author":"M Kawano","year":"2015","unstructured":"Kawano M, Tanaka K, Itonaga I, Ikeda S, Iwasaki T, Tsumura H. microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells. J Exp Clin Cancer Res. 2015;34:76.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"307_CR19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1053\/j.gastro.2013.09.037","volume":"145","author":"M Donadelli","year":"2013","unstructured":"Donadelli M, Palmieri M. Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma. Gastroenterology. 2013;145(5):936\u20138.","journal-title":"Gastroenterology"},{"issue":"16","key":"307_CR20","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.febslet.2012.06.003","volume":"586","author":"HC He","year":"2012","unstructured":"He HC, Zhu JG, Chen XB, Chen SM, Han ZD, Dai QS, et al. MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer. FEBS Lett. 2012;586(16):2451\u20138.","journal-title":"FEBS Lett"},{"key":"307_CR21","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/onc.2011.431","volume":"31","author":"P Russell","year":"2012","unstructured":"Russell P, Hennessy BT, Li J, Carey MS, Bast RC, Freeman T, et al. Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest. Oncogene. 2012;31:2450\u201360.","journal-title":"Oncogene"},{"key":"307_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/excr.1996.3402","volume":"230","author":"ML Smith","year":"1997","unstructured":"Smith ML, Kontny HU, Bortnick Jr R, Fornace AJ. The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity. Exp Cell Res. 1997;230:61\u20138.","journal-title":"Exp Cell Res"},{"key":"307_CR23","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1038\/sj.onc.1202821","volume":"18","author":"K Okamoto","year":"1999","unstructured":"Okamoto K, Prives C. A role of cyclin G in the process of apoptosis. Oncogene. 1999;18:4606\u201315.","journal-title":"Oncogene"},{"issue":"9","key":"307_CR24","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1158\/1535-7163.MCT-13-0099","volume":"12","author":"W Wen","year":"2013","unstructured":"Wen W, Han T, Chen C, Huang L, Sun W, Wang X, et al. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt\/mTOR signaling. Mol Cancer Ther. 2013;12(9):1796\u2013804.","journal-title":"Mol Cancer Ther"},{"key":"307_CR25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/(SICI)1097-0215(19961220)69:6<475::AID-IJC10>3.0.CO;2-0","volume":"69","author":"ME Burg van der","year":"1996","unstructured":"van der Burg ME, Henzen-Logmans SC, Berns EM, van Putten WL, Klijn JG, Foekens JA. Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors. Int J Cancer. 1996;69:475\u20139.","journal-title":"Int J Cancer"},{"issue":"11\u201312","key":"307_CR26","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/sj.bjc.6690278","volume":"79","author":"W Kuhn","year":"1999","unstructured":"Kuhn W, Schmalfeldt B, Reuning U, Pache L, Berger U, Ulm K, et al. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer. 1999;79(11\u201312):1746\u201351.","journal-title":"Br J Cancer"},{"issue":"6","key":"307_CR27","first-page":"1743","volume":"7","author":"G Konecny","year":"2001","unstructured":"Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, et al. Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer. Clin Cancer Res. 2001;7(6):1743\u20139.","journal-title":"Clin Cancer Res"},{"key":"307_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z","volume":"72","author":"PA Andreasen","year":"1997","unstructured":"Andreasen PA, Kj\u00f8ller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 1997;72:1\u201322.","journal-title":"Int J Cancer"},{"key":"307_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0065-230X(08)60028-7","volume":"44","author":"K Dan\u00f8","year":"1985","unstructured":"Dan\u00f8 K, Andreasen PA, Gr\u00f8ndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res. 1985;44:139\u2013266.","journal-title":"Adv Cancer Res"},{"key":"307_CR30","doi-asserted-by":"crossref","unstructured":"Czekay RP, Wilkins-Port CE, Higgins SP, Freytag J, Overstreet JM, Klein RM, et al. PAI-1: an integrator of cell signaling and migration. Int J Cell Biol. 2011;2011:562481.","DOI":"10.1155\/2011\/562481"},{"key":"307_CR31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1756-9966-28-152","volume":"28","author":"L Xiao","year":"2009","unstructured":"Xiao L, Wang YC, Li WS, Du Y. The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray. J Exp Clin Cancer Res. 2009;28:152.","journal-title":"J Exp Clin Cancer Res"},{"key":"307_CR32","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/sj.jid.5700469","volume":"126","author":"XQ Wang","year":"2006","unstructured":"Wang XQ, Sun P, Go L, Koti V, Fliman M, Paller AS. Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling. J Investig Dermatol. 2006;126:2687\u201396.","journal-title":"J Investig Dermatol"},{"issue":"9","key":"307_CR33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3858\/emm.2011.43.9.057","volume":"43","author":"KH Lee","year":"2011","unstructured":"Lee KH, Choi EY, Koh SA, Kim MK, Kim KO, Lee SH, et al. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB. Exp Mol Med. 2011;43(9):501\u20139.","journal-title":"Exp Mol Med"},{"key":"307_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/annonc\/mdj121","volume":"17","author":"BM Ryan","year":"2006","unstructured":"Ryan BM, Konecny GE, Kahlert S, Wang HJ, Untch M, Meng G, et al. Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol. 2006;17:597\u2013604.","journal-title":"Ann Oncol"},{"issue":"1","key":"307_CR35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1499-3872(13)60012-0","volume":"12","author":"DH Zhou","year":"2013","unstructured":"Zhou DH, Yang LN, R\u00f6der C, Kalthoff H, Trauzold A. TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells. Hepatobiliary Pancreat Dis Int. 2013;12(1):94\u20138.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"307_CR36","first-page":"164","volume":"7","author":"M Morse","year":"2005","unstructured":"Morse M. Technology evaluation: Rexin-G, Epeius Biotechnologies. Curr Opin Mol Ther. 2005;7:164\u20139.","journal-title":"Curr Opin Mol Ther"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-016-0307-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T01:49:01Z","timestamp":1498268941000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-016-0307-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1186\/s13046-016-0307-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,13]]},"article-number":"31"}}